CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and ...

SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare

Related Keywords

California ,United States ,South San Francisco ,Sasha King ,Deborah Jo Levine ,Amishi Desai ,Caredx Allosure ,Cian Cooney ,Neeraj Singh ,Abdolreza Haririan ,Kidney International ,Langone Health ,Loyola University Introduction To Multimodality Kidney Surveillance ,Company Caredx Inc ,University Of Maryland School Medicine Kidneycare ,Nasdaq ,Johnc Mcdonald Regional Transplant Center ,Health Sciences Center ,Vaccination Booster Administration ,University Of Texas ,University Of Maryland Medical Center ,Caredx Inc ,Transplant Company ,Multimodality Approach ,American Society ,Transplantation Cutting Edge ,Kidney Transplant Recipients Following ,Booster Administration ,Allosure Kidney ,Greg Seeto ,Predictive Power ,Associate Professor ,Medical Director ,Pancreas Transplantation ,Division Chief ,Transplant Nephrology ,Loyola University Introduction ,Multimodality Kidney Surveillance ,Maryland Medical Center ,Maryland School ,Medicine Kidneycare ,Improved Precision ,Donald Regional Transplant Center ,Sciences Center ,Shreveport The Entire Picture ,Critical Care Medicine ,Transplant Company Caredx ,Looking Statements This ,Annual Report ,Sasha King Chief Marketing Officer ,Relations Ian Cooney ,Money ,Ational ,